Article Text

PDF

Neuroleptic malignant syndrome and hypothyroidism.
  1. A P Moore,
  2. I A Macfarlane,
  3. L D Blumhardt
  1. Department of Neurological Science, University of Liverpool, Walton Hospital, Liverpool, United Kingdom.

    Abstract

    Two patients with primary hypothyroidism who developed neuroleptic malignant syndrome (NMS) are described. Thyroid disease might predispose to NMS by altering brain dopamine metabolism.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.